OUR CORE TECHNOLOGY
MVC utilizes mammalian cell-culture technology to develop and manufacture viral vaccines and biosimilars. Unlike traditional egg-based production platform, cell culture technology offers the following advantages in production, safety and quality.
ADVANTAGE OF CELL CULTURE
- Reduce the risk of cross contamination and cost of CIP by using disposable bioreactors.
- Prevent transmissible spongiform encephalopathies (TSE) by using serum free media.
- Maintain constant material supplies.
- Expedite scale-up production.
- Offers diverse cell-based biologics from vaccines to antibodies.
